Company: PACB
Filing Date: 2025-05-12
Form Type: 10-Q
Source: 0001299130-25-000102
Chunk: 160

Company: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Filing Date: 2025-05-12
Form: 10-Q
Item: Part I, Item 1
Chunk 160
---
ulated other comprehensive income381 422 Accumulated deficit (2,575,001)(2,148,926)Total stockholders’ equity 91,638 506,594 Total liabilities and stockholders’ equity $860,789 $1,260,447 

See accompanying notes to the condensed consolidated financial statements.

Q1 Fiscal 2025 Form 10-Q3

Table of Contents

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS(Unaudited)

Three Months Ended March 31,(In thousands, except per share amounts)20252024Revenue:Product revenue $31,113 $35,009 Service and other revenue 6,040 3,801 Total revenue 37,153 38,810 Cost of Revenue:Cost of product revenue 26,333 22,447 Cost of service and other revenue 3,778 3,738 Amortization of acquired intangible assets4,345 1,343 Loss on purchase commitment4,068 — Total cost of revenue 38,524 27,528 Gross (loss) profit(1,371)11,282 Operating Expense:Research and development 29,053 43,455 Sales, general and administrative 40,168 43,753 Impairment charges15,000 — Amortization of acquired intangible assets362,042 5,506 Change in fair value of contingent consideration(18,700)(70)Total operating expense 427,563 92,644 Operating loss (428,934)(81,362)Interest expense (1,737)(3,575)Other income, net 4,294 6,759 Loss before benefit from income taxes(426,377)(78,178)Income tax (benefit) provision(302)— Net loss(426,075)(78,178)Other comprehensive income:Unrealized loss on investments (41)(525)Comprehensive loss$(426,116)$(78,703)Net loss per share:Basic $(1.44)$(0.29)Diluted $(1.44)$(0.29)Weighted average shares outstanding used in calculating net loss per share:Basic 296,858269,578Diluted 296,858269,578

See accompanying notes to the condensed consolidated